{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:45:25Z","timestamp":1790390725509,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-024-03188-2","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T20:03:03Z","timestamp":1722456183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-0263","authenticated-orcid":false,"given":"Merve Sinem","family":"O\u011fuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1414-617X","authenticated-orcid":false,"given":"Z\u00fcleyha","family":"Bing\u00f6l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-048X","authenticated-orcid":false,"given":"Aylin","family":"P\u0131ht\u0131l\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1085-5462","authenticated-orcid":false,"given":"Pelin","family":"Karaca \u00d6zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7235-134X","authenticated-orcid":false,"given":"Melike","family":"Sar\u0131ta\u015f Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-1094","authenticated-orcid":false,"given":"Zeki","family":"K\u0131l\u0131\u00e7aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-9335","authenticated-orcid":false,"given":"Ahmet Kaya","family":"Bilge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-6518","authenticated-orcid":false,"given":"Esen","family":"K\u0131yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8309-1216","authenticated-orcid":false,"given":"G\u00fclfer","family":"Okumu\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"3188_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/88-470-0430-6","volume-title":"Diffuse lung diseases: clinical features, pathology, HRCT","author":"A Cancellieri","year":"2006","unstructured":"Cancellieri A, Maffessanti M, Dalpiaz G. Diffuse lung diseases: clinical features, pathology, HRCT. 1st ed. Milan; New York: Springer Milan; 2006.","edition":"1"},{"key":"3188_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An Official ATS\/ERS\/JRS\/ALAT Statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","volume":"378","author":"TE King","year":"2011","unstructured":"King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378:1949\u201361.","journal-title":"Lancet"},{"key":"3188_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE. Clinical course and prediction of Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2011;183:431\u201340.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/resp.12683","volume":"21","author":"G Sgalla","year":"2016","unstructured":"Sgalla G, Biffi A, Richeldi L. Idiopathic pulmonary fibrosis: diagnosis, epidemiology and natural history. Respirology. 2016;21:427\u201337.","journal-title":"Respirology"},{"key":"3188_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rmed.2015.02.002","volume":"109","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Perlman D, Tomic R. Natural history of idiopathic pulmonary fibrosis. Respir Med. 2015;109:661\u201370.","journal-title":"Respir Med"},{"key":"3188_CR7","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1164\/rccm.2111053","volume":"167","author":"AU Wells","year":"2003","unstructured":"Wells AU, Desai SR, Rubens MB, Goh NSL, Cramer D, Nicholson AG, et al. Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;167:962\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1183\/09031936.00106011","volume":"40","author":"M Mura","year":"2012","unstructured":"Mura M, Porretta MA, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J. 2012;40:101\u20139.","journal-title":"Eur Respir J"},{"key":"3188_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis. Ann Intern Med. 2012;156:684.","journal-title":"Ann Intern Med"},{"key":"3188_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12931-016-0454-0","volume":"17","author":"SH Lee","year":"2016","unstructured":"Lee SH, Kim SY, Kim DS, Kim YW, Chung MP, Uh ST, et al. Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study. Respir Res. 2016;17:131.","journal-title":"Respir Res"},{"key":"3188_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1164\/rccm.201007-1179OC","volume":"183","author":"RM du Bois","year":"2011","unstructured":"du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Six-minute-walk test in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:1231\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1164\/rccm.200604-488OC","volume":"174","author":"KR Flaherty","year":"2006","unstructured":"Flaherty KR, Andrei A-C, Murray S, Fraley C, Colby TV, Travis WD, et al. Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:803\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1164\/rccm.200302-219OC","volume":"168","author":"VN Lama","year":"2003","unstructured":"Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic Value of Desaturation during a 6-Minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168:1084\u201390.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR14","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.rmed.2006.02.004","volume":"100","author":"CJ Lettieri","year":"2006","unstructured":"Lettieri CJ, Nathan SD, Browning RF, Barnett SD, Ahmad S, Shorr AF. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med. 2006;100:1734\u201341.","journal-title":"Respir Med"},{"key":"3188_CR15","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1183\/13993003.01537-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. Eur Respir J. 2015;46:1370\u20137.","journal-title":"Eur Respir J"},{"key":"3188_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00408-011-9304-5","volume":"189","author":"D Papakosta","year":"2011","unstructured":"Papakosta D, Pitsiou G, Daniil Z, Dimadi M, Stagaki E, Rapti A, et al. Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters. Lung. 2011;189:391\u20139.","journal-title":"Lung"},{"key":"3188_CR17","first-page":"584","volume":"55","author":"AM Modrykamien","year":"2010","unstructured":"Modrykamien AM, Gudavalli R, McCarthy K, Parambil J, Echocardiography. 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Respir Care. 2010;55:584\u20138.","journal-title":"Respir Care"},{"key":"3188_CR18","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.rmed.2012.07.013","volume":"106","author":"OA Minai","year":"2012","unstructured":"Minai OA, Santacruz JF, Alster JM, Budev MM, McCarthy K. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis. Respir Med. 2012;106:1613\u201321.","journal-title":"Respir Med"},{"issue":"3","key":"3188_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1440-1843.2010.01877.x","volume":"16","author":"JJ Swigris","year":"2011","unstructured":"Swigris JJ, Olson AL, Shlobin OA, Ahmad S, Brown KK, Nathan SD. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology. 2011;16(3):439\u201345.","journal-title":"Respirology"},{"issue":"3","key":"3188_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1440-1843.2010.01877.x-52","volume":"16","author":"JJ Swigris","year":"2011","unstructured":"Swigris JJ, Olson AL, Shlobin OA, Ahmad S, Brown KK, Nathan SD. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology. 2011;16(3):439\u201345. https:\/\/doi.org\/10.1111\/j.1440-1843.2010.01877.x-52.","journal-title":"Respirology"},{"key":"3188_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40248-018-0158-z","volume":"13","author":"LH Lancaster","year":"2018","unstructured":"Lancaster LH. Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med. 2018;13:45.","journal-title":"Multidiscip Respir Med"},{"key":"3188_CR22","doi-asserted-by":"publisher","first-page":"220087","DOI":"10.1183\/16000617.0087-2022","volume":"31","author":"S Harari","year":"2022","unstructured":"Harari S, Wells AU, Wuyts WA, Nathan SD, Kirchgaessler K-U, Bengus M, et al. The 6-min walk test as a primary end-point in interstitial lung disease. Eur Respir Rev. 2022;31:220087.","journal-title":"Eur Respir Rev"},{"key":"3188_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR24","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1183\/09031936.00150314","volume":"44","author":"AE Holland","year":"2014","unstructured":"Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428\u201346.","journal-title":"Eur Respir J"},{"key":"3188_CR25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1002110","volume":"363","author":"A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis","year":"2010","unstructured":"A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis. N Engl J Med. 2010;363:620\u20138.","journal-title":"N Engl J Med"},{"key":"3188_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.rmed.2009.09.006","volume":"104","author":"JJ Swigris","year":"2010","unstructured":"Swigris JJ, Brown KK, Behr J, du Bois RM, King TE, Raghu G, et al. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med. 2010;104:296\u2013304.","journal-title":"Respir Med"},{"key":"3188_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000446607","volume":"91","author":"T Bahmer","year":"2016","unstructured":"Bahmer T, Kirsten A-M, Waschki B, Rabe KF, Magnussen H, Kirsten D, et al. Clinical correlates of reduced physical activity in idiopathic pulmonary fibrosis. Respiration. 2016;91:497\u2013502.","journal-title":"Respiration"},{"key":"3188_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1378\/chest.10-0693","volume":"139","author":"J Yorke","year":"2011","unstructured":"Yorke J, Swigris J, Russell A-M, Moosavi SH, Ng Man Kwong G, Longshaw M, et al. Dyspnea-12 is a Valid and Reliable measure of breathlessness in patients with interstitial lung disease. Chest. 2011;139:159\u201364.","journal-title":"Chest"},{"key":"3188_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.rmr.2021.04.015","volume":"38","author":"I Touil","year":"2021","unstructured":"Touil I, Keskes Boudawara N, Bouchareb S, Ben Saad A, Migaou A, Cheikh Mhamed S, et al. Facteurs pronostiques Au cours de la fibrose pulmonaire idiopathique: \u00e9tude d\u2019une cohorte tunisienne. Rev Mal Respir. 2021;38:681\u20138.","journal-title":"Rev Mal Respir"},{"key":"3188_CR30","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618\u2013731.","journal-title":"Eur Heart J"},{"key":"3188_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1183\/09059180.00002512","volume":"21","author":"L Nalysnyk","year":"2012","unstructured":"Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 2012;21:355\u201361.","journal-title":"Eur Respir Rev"},{"key":"3188_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12931-019-1271-z","volume":"21","author":"T Tran","year":"2020","unstructured":"Tran T, \u0160terclov\u00e1 M, Mogulkoc N, Lewandowska K, M\u00fcller V, H\u00e1jkov\u00e1 M, et al. The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis. Respir Res. 2020;21:11.","journal-title":"Respir Res"},{"key":"3188_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.rmed.2008.07.022","volume":"103","author":"A Caminati","year":"2009","unstructured":"Caminati A, Bianchi A, Cassandro R, Rosa Mirenda M, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med. 2009;103:117\u201323.","journal-title":"Respir Med"},{"key":"3188_CR34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1164\/rccm.200405-578OC","volume":"171","author":"T Eaton","year":"2005","unstructured":"Eaton T, Young P, Milne D, Wells AU. Six-Minute Walk, maximal Exercise tests. Am J Respir Crit Care Med. 2005;171:1150\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR35","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1378\/chest.129.3.746","volume":"129","author":"CJ Lettieri","year":"2006","unstructured":"Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in Advanced Idiopathic Pulmonary Fibrosis. Chest. 2006;129:746.","journal-title":"Chest"},{"key":"3188_CR36","first-page":"8","volume":"8","author":"R Gupta","year":"2020","unstructured":"Gupta R, Ruppel GL, Espiritu JRD. Exercise-Induced Oxygen Desaturation during the 6-Minute Walk Test. Med Sci. 2020;8:8.","journal-title":"Med Sci"},{"key":"3188_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1183\/13993003.00975-2015","volume":"48","author":"M Waatevik","year":"2016","unstructured":"Waatevik M, Johannessen A, Gomez Real F, Aanerud M, Hardie JA, Bakke PS, et al. Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD. Eur Respir J. 2016;48:82\u201391.","journal-title":"Eur Respir J"},{"key":"3188_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4187\/respcare.06334","volume":"64","author":"YH Khor","year":"2019","unstructured":"Khor YH, Goh NS, Glaspole I, Holland AE, McDonald CF. Exertional desaturation and prescription of ambulatory oxygen therapy in interstitial lung disease. Respir Care. 2019;64:299\u2013306.","journal-title":"Respir Care"},{"key":"3188_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1479972311407355","volume":"8","author":"C Fiore","year":"2011","unstructured":"Fiore C, Lee A, McDonald C, Hill C, Holland A. Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test? Chron Respir Dis. 2011;8:181\u20134.","journal-title":"Chron Respir Dis"},{"key":"3188_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4187\/respcare.02494","volume":"59","author":"M-L Chuang","year":"2014","unstructured":"Chuang M-L, Lin I-F, Chen S-P. Kinetics of changes in Oxyhemoglobin Saturation during walking and Cycling tests in COPD. Respir Care. 2014;59:353\u201362.","journal-title":"Respir Care"},{"key":"3188_CR41","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1378\/chest.128.4.2393","volume":"128","author":"HF Nadrous","year":"2005","unstructured":"Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005;128:2393\u20139.","journal-title":"Chest"},{"key":"3188_CR42","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.chest.2020.04.046","volume":"158","author":"CS King","year":"2020","unstructured":"King CS, Shlobin OA. The trouble with Group 3 pulmonary hypertension in interstitial lung disease. Chest. 2020;158:1651\u201364.","journal-title":"Chest"},{"key":"3188_CR43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46:1113\u201330.","journal-title":"Eur Respir J"},{"key":"3188_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000327918","volume":"82","author":"G Pitsiou","year":"2011","unstructured":"Pitsiou G, Papakosta D, Bouros D. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration. 2011;82:294\u2013304.","journal-title":"Respiration"},{"key":"3188_CR45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1440-1843.2010.01909.x","volume":"16","author":"AK Boutou","year":"2011","unstructured":"Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, Kontou PK, Chavouzis N, et al. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology. 2011;16:451\u20138.","journal-title":"Respirology"},{"key":"3188_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11325-012-0716-0","volume":"17","author":"G Pitsiou","year":"2013","unstructured":"Pitsiou G, Bagalas V, Boutou A, Stanopoulos I, Argyropoulou-Pataka P. Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia? Sleep Breath. 2013;17:447\u20138.","journal-title":"Sleep Breath"},{"key":"3188_CR47","unstructured":"Harari S, Caminati A, Cassandro R, Conti S, Madotto F, Luisi F et al. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study. Sarcoidosis, Vasc Diffus lung Dis Off J WASOG. 2015;31:297\u2013305."},{"key":"3188_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1164\/rccm.201508-1546OC","volume":"194","author":"B Ley","year":"2016","unstructured":"Ley B, Bradford WZ, Vittinghoff E, Weycker D, du Bois RM, Collard HR. Predictors of Mortality poorly predict common measures of Disease Progression in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016;194:711\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"3188_CR49","doi-asserted-by":"publisher","first-page":"106227","DOI":"10.1016\/j.cct.2020.106227","volume":"100","author":"L Lancaster","year":"2021","unstructured":"Lancaster L, Fieuw A, Meulemans J, Ford P, Nathan SD. Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis. Contemp Clin Trials. 2021;100:106227.","journal-title":"Contemp Clin Trials"},{"key":"3188_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1477-7525-10-67","volume":"10","author":"JM Bourbonnais","year":"2012","unstructured":"Bourbonnais JM, Malaisamy S, Dalal BD, Samarakoon PC, Parikh SR, Samavati L. Distance saturation product predicts health\u2013related quality of life among sarcoidosis patients. Health Qual Life Outcomes. 2012;10:67.","journal-title":"Health Qual Life Outcomes"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03188-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03188-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03188-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T20:04:31Z","timestamp":1722456271000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03188-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3188"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03188-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"6 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study protocol was approved by the \u0130stanbul Faculty of Medicine Ethics Committee approval was obtained. The study was approved by the with the number 2021\/227450 and was conducted in accordance with the standards specified in the World Medical Association Helsinki Declaration. All participants were provided with verbal and written information and written informed consent was obtained from all. As this study involved standard clinical procedures and assessments without an experimental treatment protocol, it did not require registration with a public clinical trials registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}